Back to Search
DAVID CRANDALL, M.D.
M.D.
Ophthalmology Physician
NPI: 1548294416IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
4301079493(MI)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
CREIGHTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2002
Research & Publications (20)
The acute efficacy of aripiprazole across the symptom spectrum of schizophrenia: a pooled post hoc analysis from 5 short-term studies.
PMID 19192472·J Clin Psychiatry·2009
4-observational
Effects of pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 in radiation-induced intestinal injury.
PMID 19480973·Int J Radiat Oncol Biol Phys·2009
7-preclinical
The relationship between super users' attitudes and employee experiences with clinical information systems.
PMID 19047764·Med Care Res Rev·2009
8-other
An exploratory study measuring verbal order content and context.
PMID 19467997·Qual Saf Health Care·2009
8-other
Changes in non-high-density lipoprotein cholesterol levels and triglyceride/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine.
PMID 18973991·Schizophr Res·2008
4-observational
Dose-dependent thrombus resolution due to oral plaminogen activator inhibitor (PAI)-1 inhibition with tiplaxtinin in a rat stenosis model of venous thrombosis.
PMID 18392333·Thromb Haemost·2008
7-preclinical
Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
PMID 18559859·Proc Natl Acad Sci U S A·2008
7-preclinical
Effect of tiplaxtinin (PAI-039), an orally bioavailable PAI-1 antagonist, in a rat model of thrombosis.
PMID 18624980·J Thromb Haemost·2008
7-preclinical
Biomechanical modelling of a direct vertebral translation instrumentation system: preliminary results.
PMID 18810013·Stud Health Technol Inform·2008
8-other
Characterization of the novel P-selectin inhibitor PSI-697 [2-(4-chlorobenzyl)-3-hydroxy-7,8,9,10-tetrahydrobenzo[h] quinoline-4-carboxylic acid] in vitro and in rodent models of vascular inflammation and thrombosis.
PMID 18024786·J Pharmacol Exp Ther·2008
4-observational
The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials.
PMID 18790605·Schizophr Res·2008
4-observational
p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine.
PMID 18390808·J Pharmacol Exp Ther·2008
4-observational
Redesigning care delivery through health IT implementation. Exploring Trinity Health's IT model.
PMID 19195280·J Healthc Inf Manag·2007
8-other
Neutralization of plasminogen activator inhibitor I (PAI-1) by the synthetic antagonist PAI-749 via a dual mechanism of action.
PMID 17622579·Mol Pharmacol·2007
8-other
Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks.
PMID 17644313·Schizophr Res·2007
4-observational
Development of a measure of clinical information systems expectations and experiences.
PMID 17712259·Med Care·2007
4-observational
Antimanic response to aripiprazole in bipolar I disorder patients is independent of the agitation level at baseline.
PMID 17915976·J Clin Psychiatry·2007
8-other
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
PMID 17522560·J Psychiatr Pract·2007
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2799 W GRAND BLVD, EYE CARE SERVICES
DETROIT, MI 48202 - Phone
- (313) 874-9167
Quick Facts
- NPI
- 1548294416
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile